TMAO and CVD-related diseases In addition to CVDs, TMAO promotes numerous related diseases, such as diabetes, CKD, etc., which have a burden of cardiovascular complications (133, 134)
Effects of glucagon on the pancreatic beta cell The stimulatory effect of glucagon on insulin secretion from pancreatic beta cells was established as long ago as 1965 [24] and has since been shown numerous times in a number of different model systems [25,26,27]
By mimicking both, Tirzepatide: Signals your brain that youre full, helping reduce food intake Slows digestion so you stay satisfied longer Prompts insulin release when needed Reduces glucose production in the liver Because it works on two hormone pathways rather than one, it may support more noticeable weight loss than similar medications
For glycemic control in type 2 diabetes, the SURPASS trials showed sustained A1C reductions over 40-52 weeks across all dose levels
The drug tested was Rybelsus, a pill approved only for type 2 diabetes